Alcidion Group Past Earnings Performance
Past criteria checks 0/6
Alcidion Group's earnings have been declining at an average annual rate of -27.5%, while the Healthcare Services industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 19.6% per year.
Key information
-27.5%
Earnings growth rate
-19.6%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | 19.6% |
| Return on equity | -9.7% |
| Net Margin | -22.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Alcidion Group Limited (ASX:ALC) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 16
Here's Why We're Not Too Worried About Alcidion Group's (ASX:ALC) Cash Burn Situation
Jul 24Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet
Jun 14We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely
Apr 24Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding
Jan 30Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being
Nov 13Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth
Oct 19We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow
Jul 17Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?
Jun 02Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 25When Should You Buy Alcidion Group Limited (ASX:ALC)?
Nov 02When Will Alcidion Group Limited (ASX:ALC) Breakeven?
Apr 15Calculating The Fair Value Of Alcidion Group Limited (ASX:ALC)
Mar 28Revenue & Expenses Breakdown
How Alcidion Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 37 | -8 | 32 | 0 |
| 31 Mar 24 | 39 | -7 | 33 | 0 |
| 31 Dec 23 | 40 | -5 | 34 | 0 |
| 30 Sep 23 | 40 | -4 | 33 | 0 |
| 30 Jun 23 | 40 | -4 | 32 | 0 |
| 31 Mar 23 | 40 | -2 | 30 | 0 |
| 31 Dec 22 | 40 | -1 | 28 | 0 |
| 30 Sep 22 | 37 | -3 | 27 | 0 |
| 30 Jun 22 | 34 | -4 | 26 | 0 |
| 31 Mar 22 | 31 | -6 | 25 | 0 |
| 31 Dec 21 | 28 | -7 | 24 | 0 |
| 30 Sep 21 | 27 | -5 | 22 | 0 |
| 30 Jun 21 | 26 | -2 | 20 | 0 |
| 31 Mar 21 | 24 | -2 | 19 | 0 |
| 31 Dec 20 | 22 | -3 | 18 | 0 |
| 30 Sep 20 | 20 | -3 | 17 | 0 |
| 30 Jun 20 | 19 | -3 | 17 | 0 |
| 31 Mar 20 | 18 | -2 | 14 | 0 |
| 31 Dec 19 | 18 | -1 | 10 | 0 |
| 30 Sep 19 | 17 | -1 | 7 | 0 |
| 30 Jun 19 | 17 | 0 | 4 | 0 |
| 31 Mar 19 | 13 | -1 | 4 | 0 |
| 31 Dec 18 | 10 | -2 | 4 | 0 |
| 30 Sep 18 | 7 | -2 | 3 | 0 |
| 30 Jun 18 | 4 | -2 | 3 | 0 |
| 31 Mar 18 | 4 | -2 | 3 | 0 |
| 31 Dec 17 | 3 | -2 | 3 | 0 |
| 30 Sep 17 | 3 | -2 | 4 | 0 |
| 30 Jun 17 | 3 | -2 | 4 | 0 |
| 31 Mar 17 | 4 | -3 | 4 | 0 |
| 31 Dec 16 | 4 | -3 | 4 | 0 |
| 30 Sep 16 | 4 | -3 | 4 | 0 |
| 30 Jun 16 | 4 | -3 | 3 | 0 |
| 30 Jun 15 | 5 | 0 | 3 | 0 |
| 30 Jun 14 | 2 | -1 | 1 | 0 |
Quality Earnings: ALC is currently unprofitable.
Growing Profit Margin: ALC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALC is unprofitable, and losses have increased over the past 5 years at a rate of 27.5% per year.
Accelerating Growth: Unable to compare ALC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (19%).
Return on Equity
High ROE: ALC has a negative Return on Equity (-9.68%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 14:48 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alcidion Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elyse Shapiro | Bell Potter |
| Thomas Wakim | Bell Potter |
| Elyse Shapiro | Canaccord Genuity |